期刊文献+

黑曲霉菌对獐牙菜苦苷的生物转化工艺优化 被引量:4

Biotransformation optimization of swertiamarin by Aspergillus niger
原文传递
导出
摘要 目的以獐牙菜苦苷为底物,用黑曲霉菌对獐牙菜苦苷进行生物转化,并对转化条件进行优化。方法以獐牙菜新素生成率和獐牙菜苦苷转化率为指标,考察不同培养时间、不同碳源、不同氮源、不同种类金属离子、磷酸盐、生长因子(酵母膏)、接种量、底物加入量、不同初始pH值、不同温度条件,优化獐牙菜苦苷在黑曲霉培养液中的转化条件。结果优化后的培养条件为:葡萄糖10 g/L,蛋白胨5 g/L,酵母膏5 g/L,KH2PO4 5 g/L,MgSO4 1 g/L,CaCl2 1 g/L,初始pH 6.0,接种量0.5%,底物加入量1 mg/mL,28℃,培养5 d。结论黑曲霉转化獐牙菜苦苷生成獐牙菜新素的生成率稳定在8%左右。 Objective With swertiamarin as the substrate,biotransformation conditions of swertiamarin were optimized by Aspergillus niger.Methods With productivity ratio of EHPO {(Z)-5-ethylidene-8-hydroxy-3,4,5,6,7,8-hexahydro-1H-pyrano [3,4-c] pyridine-1-one} and transformation ratio of swertiamarin as indexes,training time,carbon resource,nitrogen resource,metal ions,phosphate,growth factor(yeast extract paste),inoculum size,substrate concentration,initial pH value,and tempuraure were evaluated to optimize the biotransformation of swertiamarin.Results It confirmed the optimization cultivating condition that glucose concentration was 10 g/L,peptone concentration was 5 g/L,yeast extract paste was 5 g/L,KH2PO4 concentration was 5 g/L,MgSO4 and CaCl2 concentration was 1 g/L,initial pH value was 6.0,inoculum size was 0.5%,substrate concentration was 1 mg/mL,cultivation temperature was 28 ℃,and cultivating time was 5 d.Conclusion The biotransformation ratio for EHPO into swertiamarin biotransformed by A.niger could steadily be about 8%.
出处 《中草药》 CAS CSCD 北大核心 2011年第2期257-261,共5页 Chinese Traditional and Herbal Drugs
基金 天津市自然科学基金(08JCZDJC24700 10JCZDJC21400)
关键词 獐牙菜苦苷 獐牙菜新素 黑曲霉 培养条件 生物转化 swertiamarin EHPO {(Z)-5-ethylidene-8-hydroxy-3 4 5 6 7 8-hexahydro-1H-pyrano [3 4-c] pyridine-1-one} Aspergillus niger v.Tiegh. cultivating condition biotransformation
  • 相关文献

参考文献12

二级参考文献33

  • 1林鹏程,冶兆辉,卢永昌,赵素琴,纪兰菊,胡凤祖.HPLC法测定獐牙菜及其近缘植物中4种有效成分的含量[J].药物分析杂志,2004,24(5):502-505. 被引量:21
  • 2朱狄峰,赵筱萍,程翼宇.丹参素在Caco-2细胞单层模型中的跨膜转运研究[J].中国中药杂志,2006,31(18):1517-1521. 被引量:24
  • 3田薇,张喜民,陈朝晖,陈立仁,李永民.正交试验优选獐牙菜的提取工艺[J].中草药,2007,38(4):545-548. 被引量:5
  • 4Li Jian Chen, Li Feng, Sun Bao Hui, et al. Hepatoprotective activity of the constituents in Swertiapseudochinensis[J]. Biol Pharm Bull, 2005,28(3) :534. 被引量:1
  • 5EI-Sedawy A I, Shu Y Z, Hattori M, et al. Metabolism of swertiamarin from Swertia japonica by human intestinal bacteria [ J ]. Planta Med, 1989,55(2) :147. 被引量:1
  • 6Chang Jun, Zhao Xue Ming, Liu Chang Xiao, et al. Structure elucidation of metabolites of swertiamarin produced by Aspergillus niger[J]. J Mol Struct, 2008,878:22. 被引量:1
  • 7Chang Jun, Zhang Tie Jun, Liu Chang Xiao, et al. N-(2,4-Dimethylphenyl) benzenesulfonamide [ J ]. Acta Cryst Section E, 2007,63:3670. 被引量:1
  • 8Arursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeaility coefficients in human intestinal epithelial ( Caco-2 ) cells [ J ]. Biochem Biophys Res, 1991,175(3) :880. 被引量:1
  • 9Hilger A R, Conradi R A, Burton P S. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa[ J ]. Pharm Res, 1990,7(9) :902. 被引量:1
  • 10Li J C, Feng L, Sun B H, et al. Hepatoprotective activity of the constutuents in Swertia pseudochinensis [J]. Biol Pharm Bull, 2005, 28(3): 534-537. 被引量:1

共引文献44

同被引文献39

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部